<DOC>
	<DOC>NCT00141141</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy of Atorvastin vs Simvastatin in decreasing LDL-C in diabetic subjects with hypercholesterolemia at the end of the treatment phase.</brief_summary>
	<brief_title>Efficacy And Safety Study Of Atorvastatin Versus Simvastatin In Type 2 Diabetic Subjects With Hypercholesterolemia</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Diagnosis of type 2 diabetes mellitus LDLC &gt; 130 mg/dL Insulin therapy Clinically relevant organ disease (creatininemia &gt;2mg/dL, CHF NYHA III and IV)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>